Source:http://linkedlifedata.com/resource/pubmed/id/15501053
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
23
|
pubmed:dateCreated |
2004-10-25
|
pubmed:abstractText |
The synthesis and evaluation of a group of 2,6-, 2,7- and 3,6-bis-aminoalkylamido acridones are reported, which show a similar level of activity against telomerase in vitro compared to their acridine counterparts. Computer modelling and calculations of relative binding energies suggest an equivalent binding mode to human intramolecular G-quadruplex DNA, but with significantly reduced affinity, as a result of the limited delocalisation of the acridone chromophore compared to the acridine system. Thermal melting studies on acridone and acridine quadruplex complexes using a FRET approach support these predictions. Long-term cell proliferation studies at sub-cytotoxic doses with two representative acridones using the SKOV3 cell line, show that neither compound produces growth arrest, in contrast with the effects produced by the tri-substituted acridine compound BRACO-19. It is concluded that telomerase inhibitory activity is a necessary though by itself insufficient property in order for cellular growth arrest to occur at sub-toxic concentrations, and that tight quadruplex binding is also required.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acridines,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Telomerase,
http://linkedlifedata.com/resource/pubmed/chemical/acridone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0960-894X
|
pubmed:author |
pubmed-author:GowanSharon MSM,
pubmed-author:HaiderShozeb MSM,
pubmed-author:HarrisonR JohnRJ,
pubmed-author:InclesChristopher MCM,
pubmed-author:KellandLloyd RLR,
pubmed-author:MorrellJamesJ,
pubmed-author:NeidleStephenS,
pubmed-author:ReadMartin AMA,
pubmed-author:ReszkaAnthony PAP,
pubmed-author:RomagnoliBarbaraB
|
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5845-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15501053-Acridines,
pubmed-meshheading:15501053-Cell Line, Tumor,
pubmed-meshheading:15501053-DNA,
pubmed-meshheading:15501053-Drug Evaluation, Preclinical,
pubmed-meshheading:15501053-Enzyme Inhibitors,
pubmed-meshheading:15501053-G-Quadruplexes,
pubmed-meshheading:15501053-Humans,
pubmed-meshheading:15501053-Models, Molecular,
pubmed-meshheading:15501053-Protein Binding,
pubmed-meshheading:15501053-Telomerase
|
pubmed:year |
2004
|
pubmed:articleTitle |
Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding.
|
pubmed:affiliation |
Cancer Research UK Biomolecular Structure Group, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|